nicorandil has been researched along with Pulmonary Hypertension in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HW; Chen, YL; Chua, S; Chung, SY; Hsu, SY; Lee, FY; Leu, S; Lu, HI; Sheu, JJ; Sun, CK; Tsai, TH; Yip, HK; Zhen, YY | 1 |
| Fukayama, T; Fukushima, R; Goya, S; Nakata, TM; Tanaka, R; Yoshiyuki, R | 1 |
| Babelova, A; Brandes, RP; Buerkl, J; Hofstetter, C; Kirschning, T; Mieth, A; Neofitidou, S; Revermann, M; Schermuly, RT; Schloss, M; Schröder, K | 1 |
| Hirata, Y; Morita, T; Nagai, R; Sahara, M; Sata, M | 1 |
| Bi, LQ; Cao, Q; Wang, H; Wang, Q; Xie, WP; Yu, YZ; Zuo, XR | 1 |
| Hongo, M; Ikeda, U; Kinoshita, O; Koizumi, T; Mawatari, E; Ruan, Z; Sakai, A; Shibamoto, T; Terasawa, F; Yazaki, Y | 1 |
| Hirata, Y; Imai, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Takahashi, T; Yao, A | 1 |
1 review(s) available for nicorandil and Pulmonary Hypertension
| Article | Year |
|---|---|
New insights in the treatment strategy for pulmonary arterial hypertension.
Topics: Anticoagulants; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nicorandil; Nitric Oxide Donors; Oxygen Inhalation Therapy; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridazines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2006 |
1 trial(s) available for nicorandil and Pulmonary Hypertension
| Article | Year |
|---|---|
Levosimendan attenuates pulmonary vascular remodeling.
Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazones; Hypertension, Pulmonary; Hypoglycemic Agents; Myocardial Contraction; Nicorandil; Potassium Channels; Pulmonary Circulation; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vasodilator Agents | 2011 |
5 other study(ies) available for nicorandil and Pulmonary Hypertension
| Article | Year |
|---|---|
Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Checkpoints; Cell Line; Colchicine; Connexin 43; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hypertension, Pulmonary; Lung; Male; Matrix Metalloproteinase 9; Monocrotaline; Myocytes, Smooth Muscle; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2013 |
Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nicorandil; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyridazines; Rats, Wistar; Recovery of Function; Severity of Illness Index; Sildenafil Citrate; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Caspase 3; Cells, Cultured; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Monocrotaline; NG-Nitroarginine Methyl Ester; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Pressure | 2012 |
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; In Situ Nick-End Labeling; Natriuretic Peptide, Brain; Nicorandil; Proto-Oncogene Proteins c-bcl-2; Rats; Ventricular Remodeling | 2012 |
Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Blotting, Western; Endothelium, Vascular; Follow-Up Studies; Heart Rate; Hypertension, Pulmonary; Immunohistochemistry; Leukocyte Common Antigens; Male; Monocrotaline; Nicorandil; Nitric Oxide Synthase; P-Selectin; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2005 |